ENLV Enlivex Therapeutics
- 1.320
- +0.030+2.33%
Enlivex Therapeutics News
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Enlivex Therapeutics | 424B5: Prospectus
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 20-F: Registration statement / Annual report / Transition report
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Enlivex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
